H1N1 hemagglutinin-inhibition seroprevalence in emergency department health care workers after the first wave of the 2009 influenza pandemic

Pediatric Emergency Care

Volumn 27, Issue 9, 2011, Pages 804-807

  Kumar, Swati ^a,b,c,d   Fan, Jiang ^a,b,c   Melzer Lange, Marlene ^b,d   Trost, Jessica ^a   Havens, Peter L ^b,c,d   Willoughby, Rodney E ^b,c,d   Chusid, Michael J ^b,c,d   Henrickson, Kelly J ^a,b,c,d  

^a Midwest Respiratory Virus Program (MRVP)   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Children's Research Institute   (United States)

^d CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

health care workers; influenza; pandemic; serology

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; EMERGENCY WARD; FEMALE; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ASYMPTOMATIC DISEASES; CROSS INFECTION; EMERGENCY SERVICE, HOSPITAL; ENVIRONMENTAL EXPOSURE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOSPITALS, PEDIATRIC; HOSPITALS, PRIVATE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; PANDEMICS; PERSONNEL, HOSPITAL; SEROEPIDEMIOLOGIC STUDIES; WISCONSIN; YOUNG ADULT;

EID: 80052967973     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31822c125e     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two childrenVsouthern California. MMWR Morb Mortal Wkly Rep. 2009;58:400-402.
2. Beck ET, Jurgens LA, Kehl, SC, et al. Development of a rapid automated influenza A, influenza B, and RSVA/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus (S-OIV) epidemic in Milwaukee, Wisconsin. J Mol Diagn. 2009;12:74-81.
3. Bose ME, Beck ET, Ledeboer N, et al. Rapid semi-automated subtyping of influenza during the 2009 swine-origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol. 2009;47:2779-2786.
4. He J, Bose ME, Beck ET, et al. Rapid multiplex RT-PCR typing of influenza A and B and subtyping of influenza A into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2 and N7 including typing of novel swine-origin influenza A (H1N1) virus during the current 2009 outbreak in Milwaukee, WI. J Clin Microbiol. 2009;47:2772-2778.
5. Kumar S, Chusid MJ, Willoughby RE, et al. Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses. 2009;1:72-83.
6. Kumar S, Chusid MJ, Willoughby RE, et al. Epidemiologic observations from passive and targeted surveillance during the first wave of the 2009 H1N1 influenza pandemic in Milwaukee, WI. Viruses. 2010;2:782-795.
7. Kumar S, Havens PL, Chusid MJ, et al. Clinical and epidemiologic characteristics of pandemic H1N1 associated hospitalizations in children and adolescents in Milwaukee, WI. Pediatr Infect Dis J. 2010;29:591-594.
8. Nelson M, Spiro D, Wentworth D, et al. The early diversification of influenza A/H1N1pdm. PLoS Curr Influenza. 2009;1:RRN1126.
9. Bell DM. World Health Organization Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis. 2006;12:88-94.
10. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
11. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. Available at: Http://www.cdc.gov/h1n1flu/guidelines-infection-control.htm. Accessed October 2009.
12. Centers for Disease Control and Prevention. Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1) cases. Available at: Http://www.cdc.gov/h1n1flu/casedef.htm. Accessed October 2009.
13. Kendal AP, Pereira MS, Skehel JJ, eds. Concepts and Procedures for Laboratory-Based Influenza Surveillance. Atlanta, GA: US Department of Health and Human Services, CDC; 1982.
14. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-1952.
15. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-785. (Pubitemid 351451744)
16. Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. Nature. 2006;442:448-452. (Pubitemid 44264793)
17. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: Implications for control in health care settings. Clin Infect Dis. 2003;37:1094-1101. (Pubitemid 37323665)
18. Greenbaum JA. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009;106:20365-20370.
19. De Groot AS, Ardito M, McClaine EM, et al. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine. 2009;27:5740-5747.